All Stories

  1. Inborn Errors of Purine Salvage and Catabolism
  2. The Good, the Bad and the New about Uric Acid in Cancer
  3. Cytosolic 5′-Nucleotidase II Silencing in Lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway
  4. Cytosolic 5′-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator
  5. Evidence for a Cross-Talk Between Cytosolic 5′-Nucleotidases and AMP-Activated Protein Kinase
  6. Purine-Metabolising Enzymes and Apoptosis in Cancer
  7. Emerging Role of Purine Metabolizing Enzymes in Brain Function and Tumors
  8. Cytosolic 5′-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation
  9. Interplay between adenylate metabolizing enzymes and AMP-activated protein kinase
  10. Functions of the multi-interacting protein KIDINS220/ARMS in cancer and other pathologies
  11. Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5′-nucleotidase II
  12. IMP–GMP specific cytosolic 5′-nucleotidase regulates nucleotide pool and prodrug metabolism
  13. Cytosolic 5’-Nucleotidase II Interacts with the Leucin Rich Repeat of NLR Family Member Ipaf
  14. The purine analog fludarabine acts as a cytosolic 5′-nucleotidase II inhibitor
  15. On the Physiological Role of Cytosolic 5’-nucleotidase II (cN-II): Pathological and Therapeutical Implications.
  16. A native electrophoretic technique to study oligomerization and activity of cytosolic 5′-nucleotidase II
  17. Expression of Bovine Cytosolic 5′-Nucleotidase (cN-II) in Yeast: Nucleotide Pools Disturbance and Its Consequences on Growth and Homologous Recombination
  18. Novel metabolic aspects related to adenosine deaminase inhibition in a human astrocytoma cell line
  19. Structural basis of the substrate specificity ofBacillus cereusadenosine phosphorylase
  20. Initial Studies to Define the Physiologic Role of cN-II
  21. Active and regulatory sites of cytosolic 5′‐nucleotidase
  22. Knockdown of cytosolic 5′-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells
  23. Characterization of the adenine nucleoside specific phosphorylase of Bacillus cereus
  24. Mechanistic studies on bovine cytosolic 5′‐nucleotidase II, an enzyme belonging to the HAD superfamily
  25. 5′-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells
  26. Catabolism of exogenous deoxyinosine in cultured epithelial amniotic cells
  27. Bovine Cytosolic 5′-Nucleotidase Acts through the Formation of an Aspartate 52-Phosphoenzyme Intermediate
  28. Cytosolic 5′-nucleotidase hyperactivity in erythrocytes of Lesch–Nyhan syndrome patients
  29. Identification, Separation and Characterisation of Two Forms of Cytosolic 5′-Nucleotidase/Nucleoside Phosphotransferase in Calf Thymus
  30. Bovine cytosolic IMP/GMP-specific 5′-nucleotidase: cloning and expression of active enzyme in Escherichia coli
  31. Substrates and/or Inhibitors of IMP-GMP Specific Cytosolic 5′-Nucleotidase (cN-II)
  32. The phosphotransferase activity of cytosolic 5′-nucleotidase; a purine analog phosphorylating enzyme
  33. The Bifunctional Cytosolic 5′-Nucleotidase: Regulation of the Phosphotransferase and Nucleotidase Activities
  34. Cytosolic 5′-nucleotidase/nucleoside phosphotransferase: a single assay for a bifunctional enzyme
  35. Nucleoside phosphotransferase activity of human colon carcinoma cytosolic 5′-nucleotidase
  36. On the validity of continuous spectrophotometric assays for adenosine deaminase activity: A critical reappraisal
  37. Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: Difference between puromycin aminonucleoside and adriamycin nephrosis